Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.
1] Interfant Trial Data Center, Department of Health Sciences, University of Milano-Bicocca, Monza, Italy [2] Centro Ricerca Tettamanti, Pediatric Clinic, University of Milano-Bicocca, Monza, Italy.
P
P
De Lorenzo
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
A V
AV
Moorman
Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
R
R
Pieters
Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Z E
ZE
Dreyer
Department of Pathology, The Ohio State University, Columbus, OH, USA.
N A
NA
Heerema
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
A J
AJ
Carroll
University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.
S P
SP
Hunger
Department of Pathology and UNM Cancer Center, University of New Mexico Health Services, Albuquerque, NM, USA.
R
R
Harvey
Department of Pathology and UNM Cancer Center, University of New Mexico Health Services, Albuquerque, NM, USA.
C L
CL
Willman
Department of Biostatistics, Colleges of Medicine and Public Health and Health Professions, University of Florida, Gainesville, FL, USA.
M
M
Devidas
Interfant Trial Data Center, Department of Health Sciences, University of Milano-Bicocca, Monza, Italy.
M-G
MG
Valsecchi
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
C J
CJ
Harrison
D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007223:Infant; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D011379:Prognosis; D014178:Translocation, Genetic; D016896:Treatment Outcome
C497422:KMT2A protein, human; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase